Comparison of carcinoembryonic antigen prognostic value in serum and tumour tissue of patients with colorectal cancer

Colorectal Disease

Volumn 11, Issue 3, 2009, Pages 276-281

  Li, M ^a   Li, Ji You ^a   Zhao, A L ^a   He, J S ^a   Zhou, L X ^a   Li, Y A ^a   Gu, Jin ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Carcinoembryonic antigen; Colorectal cancer; Prognosis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOEMBRYONIC ANTIGEN; CHINA; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 60549106264     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2008.01591.x     Document Type: Article

References (38)

1. Pisani P, Parkin DM, Bray F, Ferlay J. Erratum: Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 870-3.
2. Burt RW, DiSario JA, Cannon-Albright L. Genetics of colon cancer: Impact of inheritance on colon cancer risk. Annu Rev Med 1995; 46: 371-9.
3. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics 2001. CA Cancer J Clin 2001; 51: 15-36.
4. Shu Z. Recent study on CRC in China: Early detection and novel related gene. Chin Med J 1997; 110: 309-10.
5. Ming Li, Jin Gu. Changing patterns of colorectal cancer in China over a period of 20years. World J Gastroenterol 2005; 11: 4685-8.
6. http://www.nccn.org/patients/patient_gls/_english/_colon/2_work-up.asp
7. American Joint Committee on Cancer (1997 5th edition) Cancer Staging Manual. Lippincott-Raven, Philadelphia, pp. 83-8.
8. Leeman MF, McKay JA, Murray GI. Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer. J Clin Pathol 2002; 55: 758-62.
9. Kim JC, Roh SA, Kim HC, Koo KH, Cho YK, Yu CS, Kwon YM, Kim JS. Coexpression of carcinoembryonic antigen and E-cadherin in colorectal adenocarcinoma with liver metastasis. J Gastrointest Surg 2003; 7: 931-8.
10. Gold P, Freedman SO. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965; 121: 439-62.
11. Gold P, Freedman SO. Specific carcinoembryonic antigens of the human digestive system. J Exp Med 1965; 122: 467-81.
12. Boucher D, Cournoyer D, Stanners CP, Fuks A. Studies on the control of gene expression of the carcinoembryonic antigen family in human tissue. Cancer Res 1989; 49: 847-52.
13. Thomas P, Toth CA, Saini KS, Jessup JM, Steele G. The structure, metabolism and function of the carcinoembryonic antigen gene family. Biochim Biophys Acta 1990; 1032: 177-89.
14. Thompson JA, Grunert F, Zimmermann W. Carcinoembryonic antigen gene family: Molecular biology and clinical perspectives. J Clin Lab Anal 1991; 5: 344-66.
15. Thomson DMP, Krupey J, Freedman SO, Gold P. The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. Proc Natl Acad Sci U S A 1969; 64: 161-7.
16. Lindmark G, Bergstrom R, Pahlman L, Glimelius B. The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer. Br J Cancer 1995; 71: 1090-4.
17. Blake KE, Dalbow MH, Concannon JP, Hodgson SE, Brodmerkel GJ Jr, Panahandeh AH, Zimmerman K, Headings JJ. Clinical significance of the preoperative plasma carcinoembryonic antigen (CEA) level in patients with carcinoma of the large bowel. Dis Colon Rectum 1982; 25: 24-32.
18. Wang WS, Lin JK, Chiou TJ et al. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience. Jpn J Clin Oncol 2000; 30: 12-6.
19. Louhimo J, Carpelan-Holmstrom M, Alfthan H, Stenman UH, Jarvinen HJ, Haglund C. Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer. Int J Cancer 2002; 101: 545-8.
20. Nakagoe T, Sawai T, Tsuji T et al. Prognostic value of circulating CA199 in colorectal cancer patients. Acta Med Nagasaki 2002; 45: 47-51.
21. Harrison LE, Guillem JG, Paty P, Cohen AM. Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: A multivariate analysis of 572 patients. J Am Coll Surg 1997; 185: 55-9.
22. Moertel CG, O'Fallon JR, Go VL, O'Connell MJ, Thynne GS. The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer 1986; 58: 603-10.
23. Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Lamerz R. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Anticancer Res 2000; 20: 5195-8.
24. Odagiri E, Jibiki K, Shinozaki H, Nakamura S, Demura R, Demura H, Suzuki H. Carcinoembryonic antigen in serum and the tissue of patients with colon cancer. Gan No Rinsho 1984; 30: 1680-5.
25. Rosandic-Pilas M, Hadzic N, Stavljenic A, Juricic M, Scukanec-Spoljar M. Relationship between tissue and serum concentrations of carcinoembryonic antigen (CEA) in gastric and colonic carcinomas. Acta Med Austriaca 1990; 17: 89-93.
26. Moreno Carretero G, Cerdan Miguel FJ, Maestro de las Casas ML, Martinez Cortijo S, Ortega MD, Pardo Martinez M, Balibrea Cantero JL. Serum and tissue CEA in colorectal cancer: Clinical relevance. Rev Esp Enferm Dig 1998; 90: 391-401.
27. Wagener C, Muller-Wallraf R, Nisson S, Groner J, Breuer H. Localization and concentration of carcinoembryonic antigen (CEA) in gastrointestinal tumors: Correlation with CEA levels in plasma. J Natl Cancer Inst 1981; 67: 539-47.
28. Rieger A, Wahren B. CEA levels at recurrence and metastases; importance for detecting secondary disease. Scand J Gastroenterol 1975; 10: 869-74.
29. Bhatnagar J, Tewari HB, Bhatnagar M, Austin GE. Comparison of carcinoembryonic antigen in tissue and serum with grade and stage of colon cancer. Anticancer Res 1999; 19: 2181-7.
30. Goslin R, O'Brien MJ, Steele G, Mayer R, Wilson R, Corson JM, Zamcheck N. Correlation of Plasma CEA and CEA tissue staining in poorly differentiated colorectal cancer. Am J Med 1981; 71: 246-53.
31. Thomas P, Toth CA, Saini KS, Jessup JM, Steele G Jr. The structure, metabolism and function of the carcinoembryonic antigen gene family. Biochim Biophys Acta 1990; 3: 177-89.
32. Begent RH. The value of carcinoembryonic antigen measurement in clinical practice. Ann Clin Biochem 1984; 4: 231-8.
33. Wanebo HJ, Rao B, Pinsky CM, Hoffman RG, Stearns M, Schwartz MK, Oettgen HF. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 1978; 299: 448-51.
34. Slater G, Papatestas AE, Aufses AH Jr. Preoperative carcinoembryonic antigen levels in colorectal carcinoma. Arch Surg 1979; 114: 52-3.
35. Sugarbaker PH. Carcinoembryonic antigen (CEA) assays in obstructive colorectal cancer. Ann Surg 1976; 184: 752-7.
36. Wilson AP, Van Dalen A, Sibley PE, Kasper LA, Durham AP, el Shami AS. Multicentre tumour marker reference range study. Anticancer Res 1999; 19: 2749-52.
37. Rognum TO. A new approach in carcinoembryonic antigen-guided follow-up of large-bowel carcinoma patients. Scand J Gastroenterol 1986; 21: 641-9.
38. Nakagoe T, Sawai T, Ayabe H et al. Prognostic value of carcinoembryonic antigen (CEA) in tumor tissue of patients with colorectal cancer. Anticancer Res 2001; 21: 3031-6.